Murakami, M.; Ishikawa, H.; Shimizu, S.; Iwata, H.; Okimoto, T.; Takagi, M.; Murayama, S.; Akimoto, T.; Wada, H.; Arimura, T.;
et al. Optimal Androgen Deprivation Therapy Combined with Proton Beam Therapy for Prostate Cancer: Results from a Multi-Institutional Study of the Japanese Radiation Oncology Study Group. Cancers 2020, 12, 1690.
https://doi.org/10.3390/cancers12061690
AMA Style
Murakami M, Ishikawa H, Shimizu S, Iwata H, Okimoto T, Takagi M, Murayama S, Akimoto T, Wada H, Arimura T,
et al. Optimal Androgen Deprivation Therapy Combined with Proton Beam Therapy for Prostate Cancer: Results from a Multi-Institutional Study of the Japanese Radiation Oncology Study Group. Cancers. 2020; 12(6):1690.
https://doi.org/10.3390/cancers12061690
Chicago/Turabian Style
Murakami, Motohiro, Hitoshi Ishikawa, Shosei Shimizu, Hiromitsu Iwata, Tomoaki Okimoto, Masaru Takagi, Shigeyuki Murayama, Tetsuo Akimoto, Hitoshi Wada, Takeshi Arimura,
and et al. 2020. "Optimal Androgen Deprivation Therapy Combined with Proton Beam Therapy for Prostate Cancer: Results from a Multi-Institutional Study of the Japanese Radiation Oncology Study Group" Cancers 12, no. 6: 1690.
https://doi.org/10.3390/cancers12061690
APA Style
Murakami, M., Ishikawa, H., Shimizu, S., Iwata, H., Okimoto, T., Takagi, M., Murayama, S., Akimoto, T., Wada, H., Arimura, T., Sato, Y., Gosho, M., Nakamura, K., & Sakurai, H.
(2020). Optimal Androgen Deprivation Therapy Combined with Proton Beam Therapy for Prostate Cancer: Results from a Multi-Institutional Study of the Japanese Radiation Oncology Study Group. Cancers, 12(6), 1690.
https://doi.org/10.3390/cancers12061690
